AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 60 filers reported holding AURA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,484,377 | -48.5% | 722,896 | -29.1% | 0.17% | -42.0% |
| Q2 2023 | $12,593,999 | +33.1% | 1,019,757 | 0.0% | 0.30% | +32.7% |
| Q1 2023 | $9,463,345 | -11.6% | 1,019,757 | 0.0% | 0.23% | -12.4% |
| Q4 2022 | $10,707,449 | -41.8% | 1,019,757 | +0.4% | 0.26% | -45.7% |
| Q3 2022 | $18,406,000 | +28.8% | 1,015,757 | +0.7% | 0.48% | +14.2% |
| Q2 2022 | $14,295,000 | -35.5% | 1,008,814 | +0.1% | 0.42% | -25.4% |
| Q1 2022 | $22,179,000 | +29.6% | 1,008,114 | 0.0% | 0.56% | +41.3% |
| Q4 2021 | $17,118,000 | – | 1,008,114 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $37,542,666 | 10.52% |
| Regency Capital Management Inc.\DE | 532,333 | $6,574,313 | 5.72% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,622,663 | 1.14% |
| Nantahala Capital Management | 803,325 | $9,921,064 | 0.96% |
| Matrix Capital Management Company, LP | 5,362,870 | $66,231,445 | 0.77% |
| Eventide Asset Management | 2,935,519 | $36,253,660 | 0.61% |
| Rock Springs Capital Management LP | 1,019,757 | $12,593,999 | 0.30% |
| Long Focus Capital Management, LLC | 180,175 | $2,225,161 | 0.10% |
| LEVIN CAPITAL STRATEGIES, L.P. | 70,000 | $864,500 | 0.10% |
| TBH Global Asset Management, LLC | 33,097 | $408,752 | 0.08% |